These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

615 related articles for article (PubMed ID: 25208622)

  • 1. Potential therapeutic implications of gelsolin in Alzheimer's disease.
    Ji L; Zhao X; Hua Z
    J Alzheimers Dis; 2015; 44(1):13-25. PubMed ID: 25208622
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-amyloidogenic, anti-oxidant and anti-apoptotic role of gelsolin in Alzheimer's disease.
    Chauhan V; Ji L; Chauhan A
    Biogerontology; 2008 Dec; 9(6):381-9. PubMed ID: 18704746
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trichostatin A increases the levels of plasma gelsolin and amyloid beta-protein in a transgenic mouse model of Alzheimer's disease.
    Yang W; Chauhan A; Mehta S; Mehta P; Gu F; Chauhan V
    Life Sci; 2014 Mar; 99(1-2):31-6. PubMed ID: 24486299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How do membranes initiate Alzheimer's Disease? Formation of toxic amyloid fibrils by the amyloid β-protein on ganglioside clusters.
    Matsuzaki K
    Acc Chem Res; 2014 Aug; 47(8):2397-404. PubMed ID: 25029558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A method for evaluating the level of soluble β-amyloid(1-40/1-42) in Alzheimer's disease based on the binding of gelsolin to β-amyloid peptides.
    Yu Y; Zhang L; Li C; Sun X; Tang D; Shi G
    Angew Chem Int Ed Engl; 2014 Nov; 53(47):12832-5. PubMed ID: 25244702
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of trichostatin A on gelsolin levels, proteolysis of amyloid precursor protein, and amyloid beta-protein load in the brain of transgenic mouse model of Alzheimer's disease.
    Yang W; Chauhan A; Wegiel J; Kuchna I; Gu F; Chauhan V
    Curr Alzheimer Res; 2014; 11(10):1002-11. PubMed ID: 25387339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The pathophysiology of Alzheimer's disease with special reference to "amyloid cascade hypothesis"].
    Tamaoka A
    Rinsho Byori; 2013 Nov; 61(11):1060-9. PubMed ID: 24450113
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Involvement of beta-amyloid in the etiology of Alzheimer's disease].
    Tomiyama T
    Brain Nerve; 2010 Jul; 62(7):691-9. PubMed ID: 20675873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytoplasmic gelsolin increases mitochondrial activity and reduces Abeta burden in a mouse model of Alzheimer's disease.
    Antequera D; Vargas T; Ugalde C; Spuch C; Molina JA; Ferrer I; Bermejo-Pareja F; Carro E
    Neurobiol Dis; 2009 Oct; 36(1):42-50. PubMed ID: 19607917
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nardilysin prevents amyloid plaque formation by enhancing α-secretase activity in an Alzheimer's disease mouse model.
    Ohno M; Hiraoka Y; Lichtenthaler SF; Nishi K; Saijo S; Matsuoka T; Tomimoto H; Araki W; Takahashi R; Kita T; Kimura T; Nishi E
    Neurobiol Aging; 2014 Jan; 35(1):213-22. PubMed ID: 23954170
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transthyretin stabilization by iododiflunisal promotes amyloid-β peptide clearance, decreases its deposition, and ameliorates cognitive deficits in an Alzheimer's disease mouse model.
    Ribeiro CA; Oliveira SM; Guido LF; Magalhães A; Valencia G; Arsequell G; Saraiva MJ; Cardoso I
    J Alzheimers Dis; 2014; 39(2):357-70. PubMed ID: 24169237
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuropathology and biochemistry of Aβ and its aggregates in Alzheimer's disease.
    Thal DR; Walter J; Saido TC; Fändrich M
    Acta Neuropathol; 2015 Feb; 129(2):167-82. PubMed ID: 25534025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ongoing search for small molecules to study metal-associated amyloid-β species in Alzheimer's disease.
    Savelieff MG; DeToma AS; Derrick JS; Lim MH
    Acc Chem Res; 2014 Aug; 47(8):2475-82. PubMed ID: 25080056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid beta peptide load is correlated with increased beta-secretase activity in sporadic Alzheimer's disease patients.
    Li R; Lindholm K; Yang LB; Yue X; Citron M; Yan R; Beach T; Sue L; Sabbagh M; Cai H; Wong P; Price D; Shen Y
    Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3632-7. PubMed ID: 14978286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aβ secretion and plaque formation depend on autophagy.
    Nilsson P; Loganathan K; Sekiguchi M; Matsuba Y; Hui K; Tsubuki S; Tanaka M; Iwata N; Saito T; Saido TC
    Cell Rep; 2013 Oct; 5(1):61-9. PubMed ID: 24095740
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gelsolin as therapeutic target in Alzheimer's disease.
    Carro E
    Expert Opin Ther Targets; 2010 Jun; 14(6):585-92. PubMed ID: 20433353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropep-1 ameliorates learning and memory deficits in an Alzheimer's disease mouse model, increases brain-derived neurotrophic factor expression in the brain, and causes reduction of amyloid beta plaques.
    Shin MK; Kim HG; Baek SH; Jung WR; Park DI; Park JS; Jo DG; Kim KL
    Neurobiol Aging; 2014 May; 35(5):990-1001. PubMed ID: 24268884
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blocking the apolipoprotein E/amyloid-beta interaction as a potential therapeutic approach for Alzheimer's disease.
    Sadowski MJ; Pankiewicz J; Scholtzova H; Mehta PD; Prelli F; Quartermain D; Wisniewski T
    Proc Natl Acad Sci U S A; 2006 Dec; 103(49):18787-92. PubMed ID: 17116874
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intravenous infusion of monocytes isolated from 2-week-old mice enhances clearance of Beta-amyloid plaques in an Alzheimer mouse model.
    Hohsfield LA; Humpel C
    PLoS One; 2015; 10(4):e0121930. PubMed ID: 25830951
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.